Publications by authors named "Tom Barr"

Claim this Profile
H
Heterogeneity of Phenotype and Function Reflects the Multistage Development of T Follicular Helper Cells.
Marta Trüb, Tom A Barr, Vicky L Morrison, Sheila Brown, Stefano Caserta

Front Immunol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage origin limits functional plasticity in helminth-bacterial co-infection.
Dominik Rückerl, Sharon M Campbell, Sheelagh Duncan, Tara E Sutherland, Stephen J Jenkins, Tom A Barr

PLoS Pathog· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cell homeostasis: the effects of chronic antigen stimulation and inflammation.
Tom Slocombe, Sheila Brown, Katherine Miles, Mohini Gray, Tom A Barr

J Immunol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutting edge: IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, source.
Melanie D Leech, Tom A Barr, Darryl G Turner, Sheila Brown, Richard A O'Connor

J Immunol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells.
Stefano Caserta, Norman Nausch, Amy Sawtell, Rebecca Drummond, Tom Barr

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T(FH) memory: more or less T(FH)?
Tom Barr, David Gray

Eur J Immunol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells.
Luciën E P M van der Vlugt, Lucja A Labuda, Arifa Ozir-Fazalalikhan, Ellen Lievers, Anouk K Gloudemans, Tom A Barr

PLoS One· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cells: programmers of CD4 T cell responses.
Tom A Barr, Mohini Gray, David Gray

Infect Disord Drug Targets· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Tom A Barr, Ping Shen, Sheila Brown, Vicky Lampropoulou, Toralf Roch

J Exp Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantum dots decorated with pathogen associated molecular patterns as fluorescent synthetic pathogen models.
Tom A Barr, Martin Krembuszewski, Manish Gupta, David Gray, Juan C Mareque-Rivas

Mol Biosyst· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR-mediated loss of CD62L focuses B cell traffic to the spleen during Salmonella typhimurium infection.
Vicky L Morrison, Tom A Barr, Sheila Brown, David Gray

J Immunol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica.
Tom A Barr, Sheila Brown, Pietro Mastroeni, David Gray

J Immunol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD11c depletion severely disrupts Th2 induction and development in vivo.
Alexander T Phythian-Adams, Peter C Cook, Rachel J Lundie, Lucy H Jones, Katherine A Smith, Tom A Barr

J Exp Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation.
Mark S Wilson, Matthew D Taylor, Mary T O'Gorman, Adam Balic, Tom A Barr

Eur J Immunol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearance.
Suzanne Talbot, Sabine Tötemeyer, Masahiro Yamamoto, Shizuo Akira, Katherine Hughes, Tom Barr

Immunology· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins.
Katherine Miles, David J Clarke, Wuyuan Lu, Zaneta Sibinska, Paula E Beaumont, Tom A Barr

J Immunol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B cell intrinsic MyD88 signals drive IFN-gamma production from T cells and control switching to IgG2c.
Tom A Barr, Sheila Brown, Pietro Mastroeni, David Gray

J Immunol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virulent Salmonella enterica infections can be exacerbated by concomitant infection of the host with a live attenuated S. enterica vaccine via Toll-like receptor 4-dependent interleukin-10 production with the involvement of both TRIF and MyD88.
Gemma L Foster, Tom A Barr, Andrew J Grant, Trevelyan J McKinley, Clare E Bryant

Immunology· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate responses of B cells.
David Gray, Mohini Gray, Tom Barr

Eur J Immunol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells.
Tom A Barr, Sheila Brown, Gemma Ryan, Jiexin Zhao, David Gray

Eur J Immunol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-stimulatory agonists as immunological adjuvants.
Tom A Barr, Jennifer Carlring, Andrew W Heath

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies against cell surface antigens as very potent immunological adjuvants.
Tom Barr, Jennifer Carlring, Caterina Hatzifoti, Andrew W Heath

Vaccine· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 antibody as a potent immunological adjuvant: CD40 antibody provides the CD40 signal to B cells, but does not substitute for T cell help in responses to TD antigens.
Tom A Barr, Jennifer Carlring, Andrew W Heath

Vaccine· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvanticity of anti-cD40 in vaccine development.
Jennifer Cairing, Tom Barr, Andrew W Heath

Curr Opin Mol Ther· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 antibody as an adjuvant induces enhanced T cell responses.
Jennifer Carlring, Tom A Barr, Adele L McCormick, Andrew W Heath

Vaccine· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis